| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 4.38▼ | 4.39▼ | 4.39▼ | 4.33▲ | 4.45▼ |
| MA10 | 4.38▼ | 4.39▼ | 4.40▼ | 4.27▲ | 4.58▼ |
| MA20 | 4.39▼ | 4.40▼ | 4.39▼ | 4.45▼ | 4.43▼ |
| MA50 | 4.40▼ | 4.38▼ | 4.29▲ | 4.60▼ | 4.62▼ |
| MA100 | 4.40▼ | 4.29▲ | 4.34▲ | 4.47▼ | 4.63▼ |
| MA200 | 4.40▼ | 4.37▲ | 4.59▼ | 4.61▼ | 7.26▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.001▼ | -0.005▼ | -0.007▼ | 0.004▲ | -0.012▼ |
| RSI | 35.772▼ | 47.983▼ | 52.507▲ | 44.628▼ | 46.374▼ |
| STOCH | 48.611 | 38.592 | 39.284 | 50.196 | 37.289 |
| WILL %R | -83.333▼ | -85.714▼ | -54.545 | -70.667 | -57.980 |
| CCI | -190.054▼ | -85.153 | -2.372 | 30.379 | -63.292 |
|
Monday, August 04, 2025 11:50 AM
Detailed price information for Vanda Pharmaceuticals (VNDA-Q) from The Globe and Mail including charting and trades.
|
|
Friday, August 01, 2025 05:28 AM
Q2 2025 Earnings Call Transcript July 31, 2025 Vanda Pharmaceuticals Inc. misses on earnings expectations. Reported EPS is $-0.46 EPS, expectations were $-0.34. Operator: Good day, everyone, and thank ...
|
|
Friday, August 01, 2025 01:18 AM
Vanda Pharmaceuticals (NASDAQ:VNDA), a pharmaceutical company focused on central nervous system and rare disease treatments, reported financial results for Q2 2025 on July 31, 2025.
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 15/08/25 | 4.46 | 4.46 | 4.36 | 4.36 | 942,442 |
| 14/08/25 | 4.33 | 4.465 | 4.30 | 4.43 | 342,375 |
| 13/08/25 | 4.31 | 4.45 | 4.31 | 4.36 | 486,624 |
| 12/08/25 | 4.18 | 4.37 | 4.17 | 4.31 | 569,639 |
| 11/08/25 | 4.26 | 4.275 | 4.15 | 4.19 | 457,932 |
| 08/08/25 | 4.21 | 4.23 | 4.16 | 4.20 | 305,449 |
| 07/08/25 | 4.22 | 4.22 | 4.14 | 4.20 | 310,692 |
| 06/08/25 | 4.20 | 4.26 | 4.145 | 4.22 | 485,040 |
| 05/08/25 | 4.24 | 4.28 | 4.1701 | 4.21 | 365,777 |
| 04/08/25 | 4.20 | 4.275 | 4.15 | 4.26 | 598,658 |
|
|
||||
|
|
||||
|
|